Patients with a history of hypersensitivity to components of botulinum toxin type B
(botulinum toxin type B, human serum albumin, succinate buffer) or other botulinum toxin
Patients who received botulinum toxin formulation within 4 months before study drug administration or who have continued efficacy of botulinum toxin at the time of administration of investigational drug even when administered more than 4 months ago
Patients who received endothelin receptor antagonist within 60 days before study drug administration
Patients who received the following medications within 14 days prior to study drug administration
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.